Diagnostic News and Research

RSS

Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter

Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled and treated the first patient in its SHINE clinical study in Europe.

From Johnson & Johnson 15 Mar 2018

Leicester research could help identify people with asthma of different severities

A team of researchers from the NIHR Leicester Biomedical Research Centre – a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University - has identified biological variations in lung tissue samples that for the first time can help identify people with mild asthma from those with moderate or severe asthma.

15 Mar 2018

Researchers develop open-source, clinically validated template for 3D-printed stethoscope

A team of researchers have developed an open-source, clinically validated template for a 3D printed stethoscope for use in areas of the world with limited access to medical supplies - places where a stethoscope could mean the difference between life and death.

14 Mar 2018

Scientists develop rapid test that could revolutionize diagnostics of infectious diseases

Scientists of the Leibniz-Institute of Photonic Technologies, Center for Sepsis Control and Care at the University Hospital Jena and Friedrich Schiller University work at a faster and cheaper alternative for hitherto time consuming pathogen diagnostics.

14 Mar 2018

Medical University of Vienna to partner with bio.logis GIM in pharmacogenetics

Within the framework of U-PGx, an EU project for promoting the use of pharmacogenetic insights in healthcare, the Medical University of Vienna will implement the Genetic Information Management Suite developed by bio.logis Genetic Information Management GmbH.

14 Mar 2018

Study reports evidence of 'systemic bias' in alcohol screening after TBI

"Has this patient been drinking?" It's a critical question for neurosurgical nurses and other professionals when evaluating patients with traumatic brain injury. But some groups of TBI patients are less likely to be screened for alcohol use, including women and younger patients, reports a study in the March issue of the Journal of Neuroscience Nursing, official journal of the American Association of Neuroscience Nurses.

13 Mar 2018

New guidelines intend to provide template for optimal, most up-to-date DMD care

Diagnostic and treatment advances are helping patients with Duchenne muscular dystrophy - one of nine major types of muscular dystrophy that affects males - live into their 30s and beyond, raising challenges in such areas as education, vocation, levels of independence, personal relationships, emotional health, and intimacy.

13 Mar 2018

Streamlined workflow could pave way for simple blood test to study cancer heterogeneity in liquid biopsy

Scientists reported the development of a robust and streamlined procedure for whole-genome copy number profiling of circulating tumor cells from a simple blood test.

13 Mar 2018

Precision oncology may improve overall survival, lower healthcare costs for advanced cancer patients

The use of advanced molecular diagnostic technologies, such as Next-Generation Sequencing-based gene panel testing, to select targeted therapies in advanced cancer patients is known as precision oncology.

13 Mar 2018

Philips introduces new ultrasound digital health device for point-of-care diagnostics in the UK

Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips’ new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.

13 Mar 2018

Study validates Xpresys Lung 2 for differential diagnosis of early stage lung cancer

Integrated Diagnostics today announced the e-publication of full results of a large prospective clinical trial validating its Xpresys Lung 2 in the peer-reviewed medical journal CHEST¸ the official journal of the American College of Chest Physicians, titled: Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC trial.

12 Mar 2018

Telemonitoring benefits remain unclear for patients with cardiac disorders

To prevent cardiac death, people with certain cardiac disorders are implanted with electronic devices designed to automatically stimulate the heartbeat or counteract serious arrhythmia if necessary.

12 Mar 2018

New tool predicts melanoma risk

Queensland researchers have come up with a “highly accurate” melanoma detection online tool that can help diagnose the condition within 90 seconds. The test can predict if a person would get the infection within the next three and a half years.

12 Mar 2018

Mystery 'disease X' warnings from WHO

The World Health Organization (WHO) has warned about a mysterious disease X that is caused by a virus and can cause a worldwide pandemic in the near future. WHO has come up with a list of diseases that can cause an outbreak or epidemic among the general population, mainly because of the lack of resources for fighting them.

12 Mar 2018

Review highlights lack of evidence-based guidelines for managing TBI in geriatric patients

When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.

8 Mar 2018

Research identifies new biomarkers for future dementia risk

Sudha Seshadri, M.D., founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, is co-leader and senior author on research announced March 6 that identifies novel biomarkers of risk for future dementia.

6 Mar 2018

New and improved CRISPR

David Liu, professor of chemistry and chemical biology at Harvard University is a pioneer of CRISPR-Cas9 gene-editing technology. He has now come up with two new upgrades for this gene editing tool that makes it better than before. These two tools are “cellular detective” and “sharp scissors”.

5 Mar 2018

Diagnostic News and Research

Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter

Leicester research could help identify people with asthma of different severities

Researchers develop open-source, clinically validated template for 3D-printed stethoscope

Scientists develop rapid test that could revolutionize diagnostics of infectious diseases

Medical University of Vienna to partner with bio.logis GIM in pharmacogenetics

Study reports evidence of 'systemic bias' in alcohol screening after TBI

New guidelines intend to provide template for optimal, most up-to-date DMD care

Streamlined workflow could pave way for simple blood test to study cancer heterogeneity in liquid biopsy

Precision oncology may improve overall survival, lower healthcare costs for advanced cancer patients

Philips introduces new ultrasound digital health device for point-of-care diagnostics in the UK

Study validates Xpresys Lung 2 for differential diagnosis of early stage lung cancer

Telemonitoring benefits remain unclear for patients with cardiac disorders

New tool predicts melanoma risk

Mystery 'disease X' warnings from WHO

Review highlights lack of evidence-based guidelines for managing TBI in geriatric patients

Research identifies new biomarkers for future dementia risk

New and improved CRISPR

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

IQuity launches pioneering RNA-based blood test to diagnose fibromyalgia

Scientists evaluate reliability of Zika virus diagnostics

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News